UA51187A - Method for combined treatment of breast cancer using autovaccine - Google Patents

Method for combined treatment of breast cancer using autovaccine

Info

Publication number
UA51187A
UA51187A UA2002010695A UA2002010695A UA51187A UA 51187 A UA51187 A UA 51187A UA 2002010695 A UA2002010695 A UA 2002010695A UA 2002010695 A UA2002010695 A UA 2002010695A UA 51187 A UA51187 A UA 51187A
Authority
UA
Ukraine
Prior art keywords
breast cancer
autovaccine
surgery
combined treatment
vaccine
Prior art date
Application number
UA2002010695A
Other languages
Russian (ru)
Ukrainian (uk)
Other versions
UA51187C2 (en
Inventor
Григорій Платонович Потебня
Григорий Платонович Потебня
Валерій Іванович Тарутінов
Валерий Иванович Тарутинов
Галина Степанівна Лісовенко
Галина Степановна Лисовенко
Світлана Юріївна Скляр
Светлана Юрьевна Скляр
Світлана Іванівна Шпильова
Надія Леонідівна Черемшенко
Надежда Леонидовна Черемшенко
Любов Миколаївна Кохановська
Василь Федорович Чехун
Василий Федорович Чехун
Original Assignee
Інститут Експериментальної Патології Онкології І Радіобіології Ім. Р.Є. Кавецького Нан України
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Інститут Експериментальної Патології Онкології І Радіобіології Ім. Р.Є. Кавецького Нан України filed Critical Інститут Експериментальної Патології Онкології І Радіобіології Ім. Р.Є. Кавецького Нан України
Priority to UA2002010695A priority Critical patent/UA51187C2/en
Publication of UA51187A publication Critical patent/UA51187A/en
Publication of UA51187C2 publication Critical patent/UA51187C2/en

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Способ комплексного лечения больных раком молочной железы включает в себя медикаментозную и/или лучевую терапию и хирургическое вмешательство. Через неделю после хирургического вмешательства проводят иммунизацию вакциной, полученной на основе аутологических опухолевых клеток, обработанных фильтратом культуральной жидкости штамма B.subtilis B-7025, путем трехкратного подкожного введения в дозе 3-4 мл по нарастающей с интервалом 5 дней с последующей однократной ревакцинацией через 3 месяца.A comprehensive treatment method for breast cancer patients includes drug and/or radiation therapy and surgery. One week after surgery, immunization is administered with a vaccine derived from autologous tumor cells treated with the B. subtilis B-7025 strain culture fluid filtrate. The vaccine is administered subcutaneously three times at increasing doses of 3-4 ml, spaced 5 days apart, followed by a single booster dose three months later.

UA2002010695A 2002-01-28 2002-01-28 Method for combined treatment of breast cancer using autovaccine UA51187C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UA2002010695A UA51187C2 (en) 2002-01-28 2002-01-28 Method for combined treatment of breast cancer using autovaccine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UA2002010695A UA51187C2 (en) 2002-01-28 2002-01-28 Method for combined treatment of breast cancer using autovaccine

Publications (2)

Publication Number Publication Date
UA51187A true UA51187A (en) 2002-11-15
UA51187C2 UA51187C2 (en) 2004-12-15

Family

ID=34514765

Family Applications (1)

Application Number Title Priority Date Filing Date
UA2002010695A UA51187C2 (en) 2002-01-28 2002-01-28 Method for combined treatment of breast cancer using autovaccine

Country Status (1)

Country Link
UA (1) UA51187C2 (en)

Also Published As

Publication number Publication date
UA51187C2 (en) 2004-12-15

Similar Documents

Publication Publication Date Title
CY1112473T1 (en) METHODS OF TREATMENT FOR CANCER-BASED CELLS
EA200101064A1 (en) TREATMENT OF CANCER DISEASES THROUGH COMBINED INTRODUCTION OF A DOCETIXEL WITH RECOMBINANT HUMANIZED MONOCLONAL ANTI-HER2 ANTI-TITLES
US20180215789A1 (en) Concurrent Chemotherapy and Immunotherapy
CY1115782T1 (en) PHARMACEUTICAL COMPOSITIONS FOR CANCER TREATMENT
TW200724190A (en) Radiation therapy imaging and delivery utilizing coordinated motion of gantry and couch
ID22689A (en) METHODS FOR ACTIVATING CELLS THAT PROVIDE HUMAN ANTIGENT PROPERTIES, ACTIVATED CELLS THAT INDICATE HUMAN ANTIGENT PROPERTIES, AND ITS USE
DE69433013D1 (en) PREPARATIONS AND METHODS FOR THE TREATMENT OF CANCER AND HYPERPROLIATIVE DISEASES
Mathé Immunological treatment of leukaemias
ZA202210302B (en) Bioinformatics
MX2023009376A (en) Use of antibody-drug conjugate targeting her2 in treatment of specific breast cancer.
Dische Hypoxic cell sensitisers in radiotherapy
CU22979A1 (en) IMMUNOTHERAPEUTIC COMBINATION FOR THE TREATMENT OF TUMORS OVER-EXPRESSING RECEPTORS WITH KINASE ACTIVITY IN TYPOSINE WASTE
UA51187A (en) Method for combined treatment of breast cancer using autovaccine
RU99126204A (en) METHOD FOR TREATING LUNG CANCER
ES2137172T3 (en) ANTITUMORAL VACCINES INCLUDING IL-6-TRANSFECTED CELLS.
RU2681546C1 (en) Method of emergency prevention of tick - borne encephalitis
MD2355G2 (en) Method of preimplanting preparation
CY1112476T1 (en) Production of a homogeneous vaccine preparation for cancer therapeutic treatment
RU96119817A (en) METHOD FOR TREATING INTESTINAL DYSBACTERIOSIS
RU2135178C1 (en) Method of increasing antitumor efficiency in experiment
Woodruff Immunotherapy of cancer
MX2025001881A (en) Therapy comprising anti-cd19 antibody and ezh2 modulators
RU2003111573A (en) METHOD FOR TREATING LUNG CANCER
RU2674767C1 (en) Method of immunotherapy for secondary alveolar echinococcosis
AR109456A2 (en) USE OF ET743 FOR THE PREPARATION OF A MEDICINAL PRODUCT FOR THE TREATMENT OF A HUMAN PATIENT AFFECTED BY CANCER THROUGH COMBINATION THERAPY